The Texas House Public Health Committee on Monday heard hearings on a bill that would expand the state’s medical cannabis program, FOX 44 reports. The measure would allow access to products with THC levels as high as 5%. Under current law, patients can only access low-THC products with THC concentrations up to 1%.
The measure is, in part, meant to reign in the proliferation of hemp-derived THC products, such as delta-8, which some medical cannabis consumers are relying on because of the low THC limits in the state’s medical cannabis program. Delta-8 THC products are unregulated in the state, while delta-9 products are on the state’s controlled substance schedule.
David Urbanowicz, vice president of external affairs for seed-to-sale tracking company Metrc, told FOX 44 that “there’s no safeguard in place” for delta-8 products.
The bill was left pending in the committee on Monday. The bill has an identical companion in the Senate; however, that measure has not been sent to any of the chamber’s committees. (Full Story)